Last reviewed · How we verify
Tulip
At a glance
| Generic name | Tulip |
|---|---|
| Sponsor | Medical University of Lodz |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study
- The Anifrolumab PRIM Program
- Efficacy and Safety of Combined Nanofat Injection With Either Platelet Rich Fibrin or Microneedling Versus Nanofat Injection Alone in the Treatment of Facial Atrophic Post Acne Scars (NA)
- Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users
- Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users (PHASE4)
- Saphnelo Use in Females of Child-bearing Potential
- New-Generation GMA Laryngeal Mask Airway Versus Conventional Inflatable Laryngeal Mask Airway (NA)
- GMA-Tulip, I-gel and the LMA-Supreme (LMA-S) Devices in Airway Management (GLAM-I) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |